We may earn a commission. How we review
Maximus GLP-1 Review
Men's performance and health platform offering GLP-1 alongside testosterone optimization and other protocols.
Summarize this review with
The price
Price checked 2026-08-28Starting at $199.99/mo on the Maximus brand-name shelf, verified 2026-08-28
View this planpublished microdose medication price; consultation and lab fees are separate, total not verified; standard dosing reaches $299.99/mo
Plans & payment terms
View treatment options at Maximus. Confirm the latest price and availability there.
Show all 14 plans and payment terms
What they offer
- Semaglutide (compounded, including microdose at 0.1mg)
- Tirzepatide (compounded)
- Semaglutide + glycine + B12 (Maximus describes the additive as a way to further customize and tailor the medication; no nausea benefit is claimed on the site and no Maximus-specific trial evidence was found)
- Foundayo (brand-name orforglipron tablets, from $199.99/mo, verified 2026-08-28)
- Wegovy (brand-name tablets from $249.99/mo and pens from $349.99/mo, verified 2026-08-28)
- Ozempic (brand-name injection, from $349.99/mo, verified 2026-08-28)
- Zepbound (brand-name injection, from $449.99/mo, verified 2026-08-28)
- Mounjaro (brand-name injection, from $1,249.99/mo, verified 2026-08-28)
Why consider it
- Advertised starting rate of $79.99/mo for compounded semaglutide, among the lowest headline prices we track; the same page also shows $150 per month, and lab work is billed separately
- Compounded plans are flat rate across every dose, so titrating up does not reprice your plan
- Maximus adds glycine and B12 to its compounded semaglutide, described on the site as a way to further customize and tailor the medication; it cites no clinical evidence for the combination
Worth knowing
- The advertised rates are first cycle prices. Compounded semaglutide steps up from $149.99 to $249.99 a month once the first cycle ends, and tirzepatide from $259.99 to $359.99, with lab work billed on top at $99 for the at-home kit or $19.99 to $115 for a Quest draw
- The fulfilling pharmacies are named only as initials in the help center, EVR, FCC or VIOS by state for compounded medication and The Pharmacy Hub for brand-name, and not on the product pages a shopper actually reads
- Brand-name plans are priced by dose tier, so titrating up can move you to a higher monthly rate; compounded plans stay flat across all doses
What customers say
Maximus has a solid Trustpilot TrustScore around 4.3 (roughly 830-990 reviews), while its BBB profile is F and not accredited. FDA warning letter #730095, issued June 8, 2026, cites false or misleading marketing claims for compounded semaglutide and tirzepatide. The letter concerns marketing and misbranding, not an allegation that medication was unsafe.
Read customer evidence →Coverage & care
- Availability
- All states except Alabama, Mississippi and Louisiana, per the site's GLP-1 availability page; tirzepatide microdose may carry additional state limits (verified 2026-09-03)
- Insurance
- Not accepted
- Consultation
- No consultation price is shown on the site's pricing, billing or FAQ pages (rendered check 2026-09-03); the monthly rate is described as including clinical oversight from the care team
- Shipping
- free expedited
Month-to-month plans end at the close of the current month. Committed 4, 6 and 12-month plans run through the term you agreed to at checkout and are not eligible for early termination or a partial refund, and all prescription sales are final with a zero day return window (verified 2026-09-03)
Independent research, not medical advice. Read our safety checks and sources.
All plans, payment and cancellation terms
- Consultation
- No consultation price is shown on the site's pricing, billing or FAQ pages (rendered check 2026-09-03); the monthly rate is described as including clinical oversight from the care team
- Shipping
- Free
- Insurance
- Not accepted
- Availability
- All states except Alabama, Mississippi and Louisiana, per the site's GLP-1 availability page; tirzepatide microdose may carry additional state limits (verified 2026-09-03)
Cancellation and refunds: Month-to-month plans end at the close of the current month. Committed 4, 6 and 12-month plans run through the term you agreed to at checkout and are not eligible for early termination or a partial refund, and all prescription sales are final with a zero day return window (verified 2026-09-03)
Want the standalone record? Maximus pricing, every tier with verification dates and detected promotions.
All pricing tiers
Brand Foundayo Tablets
$199 View details ↗Starting at $199.99/mo on the Maximus brand-name shelf, verified 2026-08-28
Brand Wegovy Tablets
$249 View details ↗Starting at $249.99/mo, the oral semaglutide pill, verified 2026-08-28
Brand Wegovy Pens
$349 View details ↗Starting at $349.99/mo, once-weekly injection, verified 2026-08-28
Brand Ozempic
$349 View details ↗Starting at $349.99/mo, verified 2026-08-28
Brand Zepbound
$449 View details ↗Starting at $449.99/mo, verified 2026-08-28
Brand Mounjaro
$1,249 View details ↗Starting at $1,249.99/mo, verified 2026-08-28
Microdose Semaglutide
$79 View details ↗Low-dose semaglutide for BMI as low as 22, $79.99/mo medication tier; Maximus-specific outcome evidence was not found
Microdose Tirzepatide
$99 View details ↗Low-dose tirzepatide, $99.99/mo medication tier; Maximus-specific outcome evidence was not found
Semaglutide (advertised landing rate)
$150 View details ↗'Starting at $150 per month' on the current semaglutide landing (2026-08-28); how this maps onto the starter/renewal tiers below is not stated on the page
Semaglutide (3-month starter)
$132 View details ↗$132.99/mo intro rate on 3-month starter pack, tirzepatide at the same intro price
Tirzepatide (3-month starter)
$132 View details ↗$132.99/mo intro rate on 3-month starter pack, parity with semaglutide at intro
Semaglutide (3-month ongoing)
$199 View details ↗$199.99/mo after intro period on 3-month renewals
Semaglutide (monthly)
$299 View details ↗$299.99/mo month-to-month rate, plus separate consultation ($28-35) and lab ($199-349/yr) fees
Tirzepatide (monthly)
$349 View details ↗$349.99/mo month-to-month rate
Why we reached this verdict
Maximus advertises compounded semaglutide from $79.99 a month, but that is a headline figure, not what you keep paying: the help center pricing table lists $149.99 for the first cycle then $249.99 a month, with tirzepatide at $259.99 then $359.99, lab work billed separately, and a $50 per shipment surcharge on compounded semaglutide going to California. It now sells brand-name Wegovy, Zepbound, Ozempic, Mounjaro and Foundayo alongside the compounded line. Its record also includes FDA warning letter #730095, issued June 8, 2026, over false or misleading marketing claims for compounded semaglutide and tirzepatide. The letter concerns marketing and misbranding, not an unsafe-medication finding; it is reflected in the current 5.1/10 score.
What makes it different: Only platform offering GLP-1 microdosing from $79.99/mo for BMI as low as 22, targeting the 'small weight loss' and metabolic health market.
Maximus Pros and Cons
What We Like
What We Like
- +Advertised starting rate of $79.99/mo for compounded semaglutide, among the lowest headline prices we track; the same page also shows $150 per month, and lab work is billed separately
- +Compounded plans are flat rate across every dose, so titrating up does not reprice your plan
- +Maximus adds glycine and B12 to its compounded semaglutide, described on the site as a way to further customize and tailor the medication; it cites no clinical evidence for the combination
- +Free expedited shipping on all medication orders
What Could Be Better
What Could Be Better
- −The advertised rates are first cycle prices. Compounded semaglutide steps up from $149.99 to $249.99 a month once the first cycle ends, and tirzepatide from $259.99 to $359.99, with lab work billed on top at $99 for the at-home kit or $19.99 to $115 for a Quest draw
- −The fulfilling pharmacies are named only as initials in the help center, EVR, FCC or VIOS by state for compounded medication and The Pharmacy Hub for brand-name, and not on the product pages a shopper actually reads
- −Brand-name plans are priced by dose tier, so titrating up can move you to a higher monthly rate; compounded plans stay flat across all doses
- −FDA warning letter #730095, issued June 8, 2026, cites false or misleading compounded-GLP-1 marketing claims. It is a marketing/misbranding record, not an unsafe-medication finding
Is Maximus legit? Pharmacy, prescribers and safety checks
Maximus is a real, operating telehealth company, but "legit" needs qualification: the FDA issued warning letter #730095 on 2026-06-08. It holds 4.3 out of 5 across 833 Trustpilot reviews, while its BBB profile reads F (not accredited). It scores 5.1/10 on our methodology; the six signals below are how we checked.
Six trust signals, the evidence behind them, and what remains unverified.
FDA warning letter #730095
Issued 2026-06-08. FDA review of the Maximus website in May 2026 found it offering compounded semaglutide and tirzepatide products with claims the agency deemed false or misleading, rendering them misbranded.
Received an FDA warning letter on June 8, 2026 (ref #730095) over compounded GLP-1 marketing claims. Maximus carries an affiliate tracking link on this site; the letter is disclosed here and on its review page regardless.
Read the official FDA letterVerification record for Maximus
Price checked .
Read individual claims alongside their dates and source links. A dated price check does not establish that every review detail was checked on the same day. Our editorial methodology explains the criteria.
Clinical evidence: 20.9% average body-weight reduction at 72 weeks in SURMOUNT-1 (NEJM, 2022). Individual results vary; compounded GLP-1s are not FDA-approved.
What the doctors say about GLP-1 medications
Independent, sourced clinical context on the medication class, not a comment on this provider.
“Our research highlights the safety and the potential for GLP-1 receptor agonists to reduce the risk of acute pancreatitis recurrence in individuals with obesity and type 2 diabetes, challenging previous concerns and offering new hope for effective disease management.”
“More options for people with these challenging diseases will be very helpful, particularly if the new oral tablet medicines are priced reasonably.”
Quotes are general medical commentary about GLP-1 medications, independently sourced and not solicited by GLP-1 Picks. They are not an endorsement of any provider, our provider scores are set solely by our published methodology.
Maximus reviews: what customers say
Recorded third-party ratings and source links for Maximus. “Not verified” means this review has no confirmed figure; it does not establish that no profile exists.
Maximus has a solid Trustpilot TrustScore around 4.3 (roughly 830-990 reviews), while its BBB profile is F and not accredited. FDA warning letter #730095, issued June 8, 2026, cites false or misleading marketing claims for compounded semaglutide and tirzepatide. The letter concerns marketing and misbranding, not an allegation that medication was unsafe.
Reddit: Praise for fast shipping, easy lab results, and responsive reps; recurring complaints about billing continuing after cancellation (incl. a mistaken $599 shipment) and unhelpful/non-existent customer service.
How Maximus works
Sign Up & Health Assessment
Create an account and complete a health assessment covering your medical history and weight loss goals.
Clinician Review
A licensed clinician reviews your intake and sets your dose. Maximus publishes no separate consultation price, and its pricing page lists clinical oversight from the care team as part of the monthly rate.
Medication Ships Free
If approved, medication ships with free expedited delivery. Lab work is billed separately, at $99 for the at-home kit or $19.99 to $115 for a Quest draw.